PGI3 COST-EFFECTIVENESS OF ESOMEPRAZOLE COMPARED TO PANTOPRAZOLE AND GENERIC OMEPRAZOLE IN ENDOSCOPY POSITIVE GERD PATIENTS IN GERMANY
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)66006-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)66006-8/fulltext
Title :
PGI3 COST-EFFECTIVENESS OF ESOMEPRAZOLE COMPARED TO PANTOPRAZOLE AND GENERIC OMEPRAZOLE IN ENDOSCOPY POSITIVE GERD PATIENTS IN GERMANY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66006-8&doi=10.1016/S1098-3015(10)66006-8
First page :
Section Title :
Open access? :
No
Section Order :
373